Latest News

Pilot Water and Peak Rentals moves reshape Select Water's outlook.

Immunovant drops Sjögren's and points to 2027 readouts.

Hospital uptake peaked as a subcutaneous version moves toward quarterly dosing.

Fintech and fiber growth lifted results, though data center demand slowed.

Net leverage fell to 2.3x while AppGrowth revenue climbed 42% this quarter.

Management details the shift from research toward scalable, commercial manufacturing.

Phase 3 wins set up a 2027 filing and a commercial push.

Alphabet’s sharp sell-off raises a big question: Are investors more concerned about AI spending than AI growth?

Margin expansion despite cost headwinds reveals how operational discipline is fueling profitability gains.

After over four years of strong returns, the stock market looks pricey based on some closely watched metrics.

Dreams disruption and Mattress Firm expansion shape the quarter.

BCE is yielding a very generous 5.2%, as the company's telecom business improves and long-term investments drive growth.

Learn how Thomson Reuters recovered from a 62% dip and what the future holds for its major revenue segments.

Hardware cost cuts let Peloton launch a treadmill $1,000 cheaper, while its enterprise channel continues to expand beyond the home.

Data center demand and a record EBITDA quarter shaped the results.

Intact reported $660 million in pre-tax catastrophe losses during the quarter, which dragged its net operating income per share lower.

Enbridge starts investors off with a near 5.9% dividend that can continue to grow with a steady growth profile.

Students are demanding a higher return on their investments.

AMD is still growing and is optimistic about the fourth quarter, despite recent market noise about the AI trade.

Management's push, from cutting costs to squeezing more output from existing resources, could determine whether margin gains last through the cycle.

BCE (TSX:BCE) could be a huge dividend value winner as the stock markets correct and potentially flirt with a bear market.

A $150,000 starting target can support a $6,000 annual TFSA income goal without requiring an extreme yield.

Clover Health Investments (NASDAQ:CLOV) expects another year of strong membership growth in 2027, aided by a competitor’s exit from its core New Jersey market and what it sees as favorable positioning for its Medicare Advantage plans, Chief Financial Officer Clay Thornton said. Thornton, recently a

OraSure Technologies (NASDAQ:OSUR) reported 14% year-over-year revenue growth in the third quarter of 2026, but pushed back its target for operating cash flow breakeven as the timing of several product opportunities shifted. The diagnostics and sample collection company now expects to reach operati

Lucid Group (NASDAQ:LCID) reduced its free cash outflow by 30% in the third quarter of 2026 as the electric vehicle maker cut production, sold vehicles from inventory and continued a broader cost-reduction program. The company reported revenue of $350 million, up 4% from a year earlier, and an adju